April 23, 2026 - 00:16

A groundbreaking new supplement in the American Journal of Public Health is issuing a powerful call to action, demonstrating that truly inclusive public health spaces are vital for improving the well-being of individuals with intellectual and developmental disabilities (IDD). The publication argues that meaningful inclusion must extend to involving people with IDD directly in shaping policy, funding allocations, and research agendas.
The supplement, titled “Achieving Health Equity for People with Intellectual Developmental Disabilities: Making an Elusive Goal A Reality,” leverages extensive data and programming experience from one of the world's largest organizations serving this community. It provides public health practitioners and policymakers with a clear roadmap to address the profound and often overlooked health disparities faced by people with IDD.
Central to its findings is the urgent need to transform health systems to be fully accessible and to better equip healthcare workers with the training to provide competent, respectful care. The research underscores that achieving health equity is not possible without dismantling barriers and ensuring that individuals with IDD are active participants in the decisions that affect their health and lives. This collection of work stands as a critical resource for building a more just and effective public health infrastructure for all.
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...